Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

553 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Evaluation of a diagnostic algorithm for sputum smear-negative pulmonary tuberculosis in HIV-infected adults.
Padmapriyadarsini C, Tripathy S, Sekar L, Bhavani PK, Gaikwad N, Annadurai S, Narendran G, Selvakumar N, Risbud AR, Sheta D, Rajasekaran S, Thomas A, Wares F, Swaminathan S. Padmapriyadarsini C, et al. J Acquir Immune Defic Syndr. 2013 Jul 1;63(3):331-8. doi: 10.1097/QAI.0b013e31829341af. J Acquir Immune Defic Syndr. 2013. PMID: 23599010
Effect of anticoagulants on plasma nevirapine and efavirenz concentrations.
Hemanth Kumar AK, Ramachandran G, Kumar P, Anitha S, Rajasekaran S, Swaminathan S. Hemanth Kumar AK, et al. Ther Drug Monit. 2007 Oct;29(5):652-4. doi: 10.1097/FTD.0b013e318156e73a. Ther Drug Monit. 2007. PMID: 17898659
CYP2B6 G516T polymorphism but not rifampin coadministration influences steady-state pharmacokinetics of efavirenz in human immunodeficiency virus-infected patients in South India.
Ramachandran G, Hemanth Kumar AK, Rajasekaran S, Kumar P, Ramesh K, Anitha S, Narendran G, Menon P, Gomathi C, Swaminathan S. Ramachandran G, et al. Antimicrob Agents Chemother. 2009 Mar;53(3):863-8. doi: 10.1128/AAC.00899-08. Epub 2009 Jan 5. Antimicrob Agents Chemother. 2009. PMID: 19124658 Free PMC article.
Miliary tuberculosis in human immunodeficiency virus infected patients not on antiretroviral therapy: clinical profile and response to shortcourse chemotherapy.
Swaminathan S, Padmapriyadarsini C, Ponnuraja C, Sumathi CH, Rajasekaran S, Amerandran VA, Reddy M, Deivanayagam CN. Swaminathan S, et al. J Postgrad Med. 2007 Oct-Dec;53(4):228-31. doi: 10.4103/0022-3859.37509. J Postgrad Med. 2007. PMID: 18097109 Clinical Trial.
Anti-tuberculosis drug resistance in patients with HIV and tuberculosis in South India.
Swaminathan S, Paramasivan CN, Ponnuraja C, Iliayas S, Rajasekaran S, Narayanan PR. Swaminathan S, et al. Int J Tuberc Lung Dis. 2005 Aug;9(8):896-900. Int J Tuberc Lung Dis. 2005. PMID: 16104637
Decreased bioavailability of rifampin and other antituberculosis drugs in patients with advanced human immunodeficiency virus disease.
Gurumurthy P, Ramachandran G, Hemanth Kumar AK, Rajasekaran S, Padmapriyadarsini C, Swaminathan S, Bhagavathy S, Venkatesan P, Sekar L, Mahilmaran A, Ravichandran N, Paramesh P. Gurumurthy P, et al. Antimicrob Agents Chemother. 2004 Nov;48(11):4473-5. doi: 10.1128/AAC.48.11.4473-4475.2004. Antimicrob Agents Chemother. 2004. PMID: 15504887 Free PMC article. Clinical Trial.
Malabsorption of rifampin and isoniazid in HIV-infected patients with and without tuberculosis.
Gurumurthy P, Ramachandran G, Hemanth Kumar AK, Rajasekaran S, Padmapriyadarsini C, Swaminathan S, Venkatesan P, Sekar L, Kumar S, Krishnarajasekhar OR, Paramesh P. Gurumurthy P, et al. Clin Infect Dis. 2004 Jan 15;38(2):280-3. doi: 10.1086/380795. Epub 2003 Dec 19. Clin Infect Dis. 2004. PMID: 14699462
Increase in CD4 cell counts between 2 and 3.5 years after initiation of antiretroviral therapy and determinants of CD4 progression in India.
Rajasekaran S, Jeyaseelan L, Raja K, Vijila S, Krithigaipriya KA, Kuralmozhi R. Rajasekaran S, et al. J Postgrad Med. 2009 Oct-Dec;55(4):261-6. doi: 10.4103/0022-3859.58929. J Postgrad Med. 2009. PMID: 20083872
553 results
Jump to page
Feedback